Cboe files to list staked Injective ETF from Canary Capital
Main Idea
The Cboe has filed to list Canary Capital’s staked Injective ETF, which could become the third staked crypto ETF in the U.S., following Solana and Ether ETFs, pending SEC approval.
Key Points
1. The Chicago Board Options Exchange (CBOE) submitted a 19b-4 filing to list shares of Canary Capital’s proposed staked Injective ETF.
2. If approved, this would be the third staked altcoin ETF, after staked Solana and Ether ETFs were approved on June 30.
3. The SEC has not yet formally acknowledged the filings, and the review process could take up to 240 days, with a final decision potentially delayed until March 2026.
4. In May, the SEC ruled that staking does not violate securities laws, a decision seen as a 'major step forward' for the crypto industry.
5. If approved, the Injective ETF could provide traditional investors exposure to INJ, potentially helping the token recover from its current price, which is over 71% below its all-time high.
Description
The Cboe has filed to list Canary Capital’s staked Injective ETF, potentially making it the third staked crypto ETF following Solana and Ether.
Latest News
- eToro to tokenize 100 most popular US stocks on Ethereum2025-07-29 22:30:10
- US Senate bill seeks to include crypto in mortgage approval process2025-07-29 21:56:11
- XRP open interest sheds $2.4B: Is a price crash next?2025-07-29 21:52:26
- SEC votes to allow in-kind redemptions for crypto ETPs2025-07-29 20:59:16
- Bitcoin bulls aim to chase liquidity at $122K, but Q3 seasonality could stall breakouts2025-07-29 20:34:43